Details for New Drug Application (NDA): 211132
✉ Email this page to a colleague
The generic ingredient in LEUCOVORIN CALCIUM is leucovorin calcium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 211132
Tradename: | LEUCOVORIN CALCIUM |
Applicant: | Novast Labs |
Ingredient: | leucovorin calcium |
Patents: | 0 |
Suppliers and Packaging for NDA: 211132
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 211132 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-181 | 50742-181-01 | 100 TABLET in 1 BOTTLE (50742-181-01) |
LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 211132 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-181 | 50742-181-30 | 30 TABLET in 1 BOTTLE (50742-181-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Jul 30, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jul 30, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 15MG BASE | ||||
Approval Date: | Jul 30, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription